Takenori Miyashita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takenori Miyashita has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Hiroshi Hoshikawa
3 shared publicationsHideo Shojaku
Department of Otolaryngology, Faculty of Medicine, Toyama University
2 shared publications- Hiroshi Hoshikawa
Department of Otolaryngology, Kagawa University, Kagawa, Japan
2 shared publications Masahito Tsubota
Department of Otolaryngology, Kanazawa Medical University Himi Municipal Hospital
2 shared publications- Ryuhei Inamoto
Department of Otolaryngology, Kagawa University, Kagawa, Japan
2 shared publications - Shinichi Iwasaki
Department of Otolaryngology & Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences
2 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 62
Photoimmunotherapy for recurrent or unresectable head and neck cancer: Clinical outcomes and perioperative airway management
- 23 September 2026
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 62
Open AccessPhotoimmunotherapy for recurrent or unresectable head and neck cancer: Clinical outcomes and perioperative airway management
- 13 October 2023
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (2) , 343-346
Estimated incidence and characteristics of vestibular neuritis in Japan: A nationwide survey
- 13 October 2023
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (2) , 343-346
Estimated incidence and characteristics of vestibular neuritis in Japan: A nationwide survey
- 1 June 2022
- Published by Elsevier in Auris Nasus Larynx
- Vol. 49 (3) , 347-351
Estimated prevalence and characteristics of bilateral vestibulopathy diagnosed in Japan: A nationwide survey
- 1 June 2022
- Published by Elsevier in Auris Nasus Larynx
- Vol. 49 (3) , 347-351
Estimated prevalence and characteristics of bilateral vestibulopathy diagnosed in Japan: A nationwide survey
- Open Access
- 1 July 2021
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 17 (4) , 343-347
Temporal Adjusters Can Reduce Pain During the Video Head Impulse Test for Patients With Mongoloid Facial Features, Without Increasing the Slippage-Induced Artifacts
BACKGROUND: The aim of this study was to determine whether the extent and intensity of pain caused by wearing goggles during the video head impulse test (vHIT) could be reduced by adjusting the direction in which the band pulls the goggles, without increasing the number of artifacts recorded during vHIT. METHODS: vHIT tests were performed in 65 healthy adult subjects, and the Visual Analog Scale (VAS) and Numerical Rating Scale (NRS) were used to evaluate pain intensity. Temporal adjusters were used to adjust the direction in which the band pulls the goggles, without decreasing the tightness of the temple straps. Artifacts were compared by calculating the instantaneous gains at 40 ms, 60 ms, and 80 ms of head movement. RESULTS: Maximum VAS and NRS of pain were significantly reduced from 22.0 ± 2.3 to 13.0 ± 1.7 and from 3.0 ± 0.2 to 2.0 ± 0.2 (both P < .0001). The VAS score without adjusters was significantly correlated with the improvement of the VAS score with temporal adjusters (P < .0001, r = 0.61). The higher the VAS score without adjusters, the greater the improvement in the VAS score with temporal adjusters. The instantaneous gains were close to 1.0 under both conditions. CONCLUSION: The pain induced by the goggle was significantly mitigated with temporal adjusters in the bilateral temple strap. Using temporal adjusters is a useful and easy solution to reduce discomfort during vHIT, while maintaining the tightness of the strap to decrease the slippageinduced artifacts. Cite this article as: Takahashi S, Miyashita T, Inamoto R, et al. Temporal adjusters can reduce pain during the video head impulse test for patients with mongoloid facial features, without increasing the slippage-induced artifacts. J Int Adv Otol. 2021; 17(4): 343-347.
- 1 July 2021
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 17 (4) , 343-347
Open AccessTemporal Adjusters Can Reduce Pain During the Video Head Impulse Test for Patients With Mongoloid Facial Features, Without Increasing the Slippage-Induced Artifacts
BACKGROUND: The aim of this study was to determine whether the extent and intensity of pain caused by wearing goggles during the video head impulse test (vHIT) could be reduced by adjusting the direction in which the band pulls the goggles, without increasing the number of artifacts recorded during vHIT. METHODS: vHIT tests were performed in 65 healthy adult subjects, and the Visual Analog Scale (VAS) and Numerical Rating Scale (NRS) were used to evaluate pain intensity. Temporal adjusters were used to adjust the direction in which the band pulls the goggles, without decreasing the tightness of the temple straps. Artifacts were compared by calculating the instantaneous gains at 40 ms, 60 ms, and 80 ms of head movement. RESULTS: Maximum VAS and NRS of pain were significantly reduced from 22.0 ± 2.3 to 13.0 ± 1.7 and from 3.0 ± 0.2 to 2.0 ± 0.2 (both P < .0001). The VAS score without adjusters was significantly correlated with the improvement of the VAS score with temporal adjusters (P < .0001, r = 0.61). The higher the VAS score without adjusters, the greater the improvement in the VAS score with temporal adjusters. The instantaneous gains were close to 1.0 under both conditions. CONCLUSION: The pain induced by the goggle was significantly mitigated with temporal adjusters in the bilateral temple strap. Using temporal adjusters is a useful and easy solution to reduce discomfort during vHIT, while maintaining the tightness of the strap to decrease the slippageinduced artifacts. Cite this article as: Takahashi S, Miyashita T, Inamoto R, et al. Temporal adjusters can reduce pain during the video head impulse test for patients with mongoloid facial features, without increasing the slippage-induced artifacts. J Int Adv Otol. 2021; 17(4): 343-347.
- Open Access
- 26 March 2021
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 102 (6) , 379-384
The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care
Palliative care patients with head and neck squamous cell carcinoma (HNSCC) often experience dysphagia and airway trouble; thus, each patient requires a specific palliative care plan based on their prognostication. However, no established specific prognostic tool performed on the day of starting end-of-life care is available for such patients. We assessed the accuracy of Glasgow prognostic score (GPS) and palliative prognostic index (PPI) and their combination to establish a specified prognostic tool for patients with HNSCC in end-of-life setting. A retrospective clinical chart review was undertaken on patients with HNSCC in end-of life setting who were decided in Kagawa University Hospital and National Hospital Organization Shikoku Cancer Center between April 2011 and March 2019. The patients were divided into 2 categories according to GPS (0-1 and 2) and PPI (groups A-B and C). These were combined into 4 categories (PPI group A-B and GPS score 0-1: good; PPI group A-B and GPS score 2: intermediate; PPI group C and GPS score 2: poor; and PPI group C and GPS score 0-1: others). The survival curves were compared for the former 3 categories. The median survival of the scores 0-1 and 2 on GPS were 114 (72-148) and 39 (25-52) days, respectively (P < .01). These of groups A-B and C on PPI were 79 (64-99) and 16 (9-29) days, respectively (P < .01). The median survival of the good, intermediate, and poor categories was 127 (73-149), 64 (44-80), and 15 (9-27) days, respectively (P < .01 among all categories). In this study, the survival of terminally ill patients with HNSCC can be predicted by the GPS, PPI, and their combination with sufficient probability.
- 26 March 2021
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 102 (6) , 379-384
Open AccessThe Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care
Palliative care patients with head and neck squamous cell carcinoma (HNSCC) often experience dysphagia and airway trouble; thus, each patient requires a specific palliative care plan based on their prognostication. However, no established specific prognostic tool performed on the day of starting end-of-life care is available for such patients. We assessed the accuracy of Glasgow prognostic score (GPS) and palliative prognostic index (PPI) and their combination to establish a specified prognostic tool for patients with HNSCC in end-of-life setting. A retrospective clinical chart review was undertaken on patients with HNSCC in end-of life setting who were decided in Kagawa University Hospital and National Hospital Organization Shikoku Cancer Center between April 2011 and March 2019. The patients were divided into 2 categories according to GPS (0-1 and 2) and PPI (groups A-B and C). These were combined into 4 categories (PPI group A-B and GPS score 0-1: good; PPI group A-B and GPS score 2: intermediate; PPI group C and GPS score 2: poor; and PPI group C and GPS score 0-1: others). The survival curves were compared for the former 3 categories. The median survival of the scores 0-1 and 2 on GPS were 114 (72-148) and 39 (25-52) days, respectively (P < .01). These of groups A-B and C on PPI were 79 (64-99) and 16 (9-29) days, respectively (P < .01). The median survival of the good, intermediate, and poor categories was 127 (73-149), 64 (44-80), and 15 (9-27) days, respectively (P < .01 among all categories). In this study, the survival of terminally ill patients with HNSCC can be predicted by the GPS, PPI, and their combination with sufficient probability.
- Open Access
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 15 (1) , 94-98
Unpleasantness of Amplified Environmental Sound Used in Tinnitus Sound Therapy: A Preliminary Study of Clinical Assessment
OBJECTIVES: In this study, our aim was to use environmental sounds amplified in the frequency region corresponding to the tinnitus frequency of individual patients and apply them as sound therapy in tinnitus retraining therapy (TRT). In this pilot study, we 1) investigated the unpleasantness of processed environmental sounds using the amplification, attenuation, and removal in different frequency regions; 2) compared the unpleasantness of processed sounds for older and younger groups of participants; and 3) determined the amplification level appropriate for a clinical test. MATERIALS and METHODS: We processed the sound of a river with three types of modification (amplified, attenuated, and notched) at a one-octave width of seven central frequencies, in the range 250-8000 Hz. Amplified and attenuated sounds were processed with five positive gains (+6, +12, +15.6, +18, and +20 dB) and two negative gains (-6 and -12 dB). Twenty-three older participants and 23 younger participants rated the unpleasantness of sounds using a visual analog scale. RESULTS: We found that, in the older group, there was no difference in unpleasantness among the three modifications. Older participants rated the level of unpleasantness as lower than younger participants for processed sounds in the high-frequency region. There were no marked differences among the amplification levels in the group of older participants. CONCLUSION: Based on the results, we decided that our clinical study would target older patients who had a tinnitus frequency over 4000 Hz and would compare the effect of an amplified sound with a 20 dB gain at the frequency corresponding to individual tinnitus with notched sound. Cite this article as: Manabe Y, Sato K, Fukuda S, Miyashita T. Unpleasantness of Amplified Environmental Sound Used in Tinnitus Sound Therapy: A Preliminary Study of Clinical Assessment. J Int Adv Otol 2019; 15(1): 94-8.
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 15 (1) , 94-98
Open AccessUnpleasantness of Amplified Environmental Sound Used in Tinnitus Sound Therapy: A Preliminary Study of Clinical Assessment
OBJECTIVES: In this study, our aim was to use environmental sounds amplified in the frequency region corresponding to the tinnitus frequency of individual patients and apply them as sound therapy in tinnitus retraining therapy (TRT). In this pilot study, we 1) investigated the unpleasantness of processed environmental sounds using the amplification, attenuation, and removal in different frequency regions; 2) compared the unpleasantness of processed sounds for older and younger groups of participants; and 3) determined the amplification level appropriate for a clinical test. MATERIALS and METHODS: We processed the sound of a river with three types of modification (amplified, attenuated, and notched) at a one-octave width of seven central frequencies, in the range 250-8000 Hz. Amplified and attenuated sounds were processed with five positive gains (+6, +12, +15.6, +18, and +20 dB) and two negative gains (-6 and -12 dB). Twenty-three older participants and 23 younger participants rated the unpleasantness of sounds using a visual analog scale. RESULTS: We found that, in the older group, there was no difference in unpleasantness among the three modifications. Older participants rated the level of unpleasantness as lower than younger participants for processed sounds in the high-frequency region. There were no marked differences among the amplification levels in the group of older participants. CONCLUSION: Based on the results, we decided that our clinical study would target older patients who had a tinnitus frequency over 4000 Hz and would compare the effect of an amplified sound with a 20 dB gain at the frequency corresponding to individual tinnitus with notched sound. Cite this article as: Manabe Y, Sato K, Fukuda S, Miyashita T. Unpleasantness of Amplified Environmental Sound Used in Tinnitus Sound Therapy: A Preliminary Study of Clinical Assessment. J Int Adv Otol 2019; 15(1): 94-8.
- Open Access
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 14 (2) , 312-316
Tricellulin Expression and its Deletion Effects in the Endolymphatic Sac
OBJECTIVES: Tricellulin is a tight junction (TJ)-forming protein that participates in the sealing function of tricellular TJs. Tricellulin-knockout (Tric−/−) mice show progressive hearing loss with degeneration of hair cells in the cochlea without physiological or physical disorders. In the present study, we investigated the tricellulin expression and its deletion effects in the endolymphatic sac (ES) using Tric−/− mice. MATERIALS and METHODS: The ES epithelia from wild-type (WT) mice were laser-microdissected, and RT-PCR was performed. The ES sections from Tric−/− and WT mice were immunostained with an anti-tricellulin antibody. Hematoxylin and eosin staining was performed for morphological examination. The inner ear of Tric−/− mice was perfused with biotinylation reagents, and the ES sections were observed for tracer permeability assay after applying streptavidin–Alexa Fluor 488 conjugate. RESULTS: The tricellulin expression was confirmed by RT-PCR and by immunohistochemistry in the WT ES. The ES in Tric−/− mice showed normal morphology and revealed no biotin leakage from the lumen. CONCLUSION: The ES in Tric−/− mice showed no changes in morphology or disruption in macromolecular barrier function. The effects of solute leakages in the ES of Tric−/− mice may be very limited and compensatable, or that the ES epithelia may have other sealing system covering the lack of tricellulin. Cite this article as: Matsubara A, Miyashita T, Inamoto R, Sakaguchi H, Kamitani T, Mori N, et al. Tricellulin Expression and its Deletion Effects in the Endolymphatic Sac. J Int Adv Otol 2018; 14(2): 312-6.
- 3 September 2019
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 14 (2) , 312-316
Open AccessTricellulin Expression and its Deletion Effects in the Endolymphatic Sac
OBJECTIVES: Tricellulin is a tight junction (TJ)-forming protein that participates in the sealing function of tricellular TJs. Tricellulin-knockout (Tric−/−) mice show progressive hearing loss with degeneration of hair cells in the cochlea without physiological or physical disorders. In the present study, we investigated the tricellulin expression and its deletion effects in the endolymphatic sac (ES) using Tric−/− mice. MATERIALS and METHODS: The ES epithelia from wild-type (WT) mice were laser-microdissected, and RT-PCR was performed. The ES sections from Tric−/− and WT mice were immunostained with an anti-tricellulin antibody. Hematoxylin and eosin staining was performed for morphological examination. The inner ear of Tric−/− mice was perfused with biotinylation reagents, and the ES sections were observed for tracer permeability assay after applying streptavidin–Alexa Fluor 488 conjugate. RESULTS: The tricellulin expression was confirmed by RT-PCR and by immunohistochemistry in the WT ES. The ES in Tric−/− mice showed normal morphology and revealed no biotin leakage from the lumen. CONCLUSION: The ES in Tric−/− mice showed no changes in morphology or disruption in macromolecular barrier function. The effects of solute leakages in the ES of Tric−/− mice may be very limited and compensatable, or that the ES epithelia may have other sealing system covering the lack of tricellulin. Cite this article as: Matsubara A, Miyashita T, Inamoto R, Sakaguchi H, Kamitani T, Mori N, et al. Tricellulin Expression and its Deletion Effects in the Endolymphatic Sac. J Int Adv Otol 2018; 14(2): 312-6.
- 1 June 2016
- Published by Elsevier in Auris Nasus Larynx
- Vol. 43 (3) , 247-253
Usefulness of multislice-CT using multiplanar reconstruction in the preoperative assessment of the ossicular lesions in the middle ear diseases
- 1 June 2016
- Published by Elsevier in Auris Nasus Larynx
- Vol. 43 (3) , 247-253
Usefulness of multislice-CT using multiplanar reconstruction in the preoperative assessment of the ossicular lesions in the middle ear diseases